| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.064 | 0.7 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |